Cellectar to participate at upcoming institutional investor conferences

Florham park, n.j., march 11, 2021 (globe newswire) -- cellectar biosciences, inc. (nasdaq: clrb), a late-stage clinical biopharmaceutical company focused on the discovery, development, and commercialization of drugs for the treatment of cancer, today announced that james caruso, president and ceo, will present a company overview and be available for 1x1 meetings at the following upcoming conferences:
CLRB Ratings Summary
CLRB Quant Ranking